These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 15631547)

  • 1. Cinacalcet hydrochloride: a viewpoint by Sharon M. Moe.
    Moe SM
    Drugs; 2005; 65(2):282-3. PubMed ID: 15631547
    [No Abstract]   [Full Text] [Related]  

  • 2. Cinacalcet hydrochloride: a viewpoint by Pablo Ureña Torres.
    Ureña Torres P
    Drugs; 2005; 65(2):282-3. PubMed ID: 15631546
    [No Abstract]   [Full Text] [Related]  

  • 3. Is it worth correcting hyperparathyroidism if hyperphosphatemia and hypocalcemia worsen? A cinacalcet story.
    Kalantar-Zadeh K; Kovesdy CP
    Am J Kidney Dis; 2009 Feb; 53(2):183-8. PubMed ID: 19166796
    [No Abstract]   [Full Text] [Related]  

  • 4. Cinacalcet for secondary hyperparathyroidism in hemodialysis recipients.
    Owda AK; Alam MG; Kumar J
    N Engl J Med; 2004 Jul; 351(2):188-9; author reply 188-9. PubMed ID: 15247361
    [No Abstract]   [Full Text] [Related]  

  • 5. Cost-utility analysis of cinacalcet in addition to standard of care in the UK.
    Ray JA; Valentine WJ; Palmer AJ
    Nephrol Dial Transplant; 2007 Nov; 22(11):3355-7; author reply 3357-8. PubMed ID: 17785347
    [No Abstract]   [Full Text] [Related]  

  • 6. Regression of parathyroid gland swelling by treatment with cinacalcet.
    Terawaki H; Nakano H; Takeguchi F; Hasegawa T; Nakayama M; Okazaki M; Hosoya T
    Nephrol Dial Transplant; 2009 Feb; 24(2):690-1; author reply 691-2. PubMed ID: 18987257
    [No Abstract]   [Full Text] [Related]  

  • 7. [Calcimimetic drugs in stage 3-5 chronic kidney disease].
    Grzegorzewska AE; Niepolski L
    Pol Merkur Lekarski; 2012 Apr; 32(190):260-2. PubMed ID: 22708286
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cinacalcet, fetuin-A and interleukin-6.
    Marino A; Giotta N
    Nephrol Dial Transplant; 2008 Apr; 23(4):1460-1; author reply 1461-2. PubMed ID: 18065786
    [No Abstract]   [Full Text] [Related]  

  • 9. Trials in kidney disease--time to EVOLVE.
    Perkovic V; Neal B
    N Engl J Med; 2012 Dec; 367(26):2541-2. PubMed ID: 23121375
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of cinacalcet on vascular calcification in haemodialysis patients.
    Almirall J; Gallardo X; Castañé E
    Nephrol Dial Transplant; 2010 Aug; 25(8):2800. PubMed ID: 20501465
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of nodular hyperplasia with resistance to cinacalcet therapy for secondary hyperparathyroidism in hemodialysis patients.
    Hirai T; Nakashima A; Takasugi N; Yorioka N
    Ther Apher Dial; 2010 Dec; 14(6):577-82. PubMed ID: 21118366
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cinacalcet should be used to treat secondary hyperparathyroidism in stage 3-4 chronic kidney disease.
    de Francisco AL; Piñera C; Palomar R
    Nat Clin Pract Nephrol; 2008 Jul; 4(7):366-7. PubMed ID: 18506170
    [No Abstract]   [Full Text] [Related]  

  • 13. Massive soft tissue calcifications in severe hyperparathyroidism secondary to end-stage renal disease.
    Staszków M; Wojtaszek E; Żebrowski P; Matuszkiewicz-Rowińska J
    Pol Arch Med Wewn; 2013; 123(4):191-2. PubMed ID: 23648814
    [No Abstract]   [Full Text] [Related]  

  • 14. Treatment of secondary hyperparathyroidism with parathyroidectomy instead of cinacalcet: time to pick the low-hanging fruit?
    Yuan CM; Nee R; Narayan R; Abbott KC
    Am J Kidney Dis; 2012 Aug; 60(2):179-81. PubMed ID: 22805518
    [No Abstract]   [Full Text] [Related]  

  • 15. Cinacalcet should not be used to treat secondary hyperparathyroidism in stage 3-4 chronic kidney disease.
    Coyne DW
    Nat Clin Pract Nephrol; 2008 Jul; 4(7):364-5. PubMed ID: 18477990
    [No Abstract]   [Full Text] [Related]  

  • 16. Cinacalcet hydrochloride.
    Barman Balfour JA; Scott LJ
    Drugs; 2005; 65(2):271-81. PubMed ID: 15631545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreases in parathyroid gland volume after cinacalcet treatment in hemodialysis patients with secondary hyperparathyroidism.
    Ichii M; Ishimura E; Okuno S; Chou H; Kato Y; Tsuboniwa N; Nagasue K; Maekawa K; Yamakawa T; Inaba M; Nishizawa Y
    Nephron Clin Pract; 2010; 115(3):c195-202. PubMed ID: 20413997
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Management of secondary hyperparathyroidism].
    Cunningham J
    Clin Calcium; 2005 Sep; 15 Suppl 1():217-24. PubMed ID: 16279027
    [No Abstract]   [Full Text] [Related]  

  • 19. [Retrospective assessment of effective and safety of cinacalcet for the treatment of secondary hyperparathyroidism depending on basal iPTH level].
    Mercadal Orfila G; Blasco Mascaró I
    Farm Hosp; 2012; 36(1):11-5. PubMed ID: 21514862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cinacalcet for managing secondary hyperparathyroidism in dialysis patients in clinical practice in Belgium: a 16-month observational study (ECHO-B).
    Debelle F; Meeus G; Dratwa M; Maes B; Vanholder R; Albert A; Schutyser E; Jadoul M
    Acta Clin Belg; 2013; 68(4):275-81. PubMed ID: 24455797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.